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Problem identification and
description of need





80% of people will get an




HPV infection is associated
with cervical, head and
neck, anal, vulvar and
vaginal, and penile cancer.³
In the United States, HPV
causes around 35,000 cases
of cancer in men and
women each year.²





prevent 90% of HPV-
associated cancers (around





The HPV vaccine is
not required by
school districts.⁷
The HPV vaccine is not
included in the requires
vaccinations for
Connecituct schools.⁷
There are many misconceptions about the
HPV vaccine.¹¹
Parents cited the need for more information, concerns about
the vaccine's effect on sexual behavior, perceived low risk of
HPV infection, cost, social influences, and limited preventative
care as common barriers to HPV vaccination.¹¹ Healthcare
professionals cited financial concerns and parental concerns
as common barriers to providing the HPV vaccine to their
pediatric patients.¹¹
02B
Current HPV vaccination protocol saves
approximately $35,000 per quality adjusted
life year (QALY)¹⁰
Expanding vaccination of adults through age 45 does not have
favorable cost-effectiveness.¹⁰
Public health cost and unique cost
considerations in host community
03A
54.7% of CT females 13-17 are 
up-to-date for HPV vaccine⁵
Although this meets the Healthy Connecticut 2020 goal of 52.3%,⁶
it does not meet the Healthy People 2020 goal of 80%.⁹
Public health cost and unique cost








































Fairfield County has the









Number of children with medical and







"The problem is that the HPV vaccine isn't
required by the school district. This is a big
issue, especially in this community, since
many parents cite that as a reason to refuse
or delay the HPV vaccine."
Darlene Benson, RN
"Something that most people don't realize is






















the identified need to
address parents'
concerns surrounding
the efficacy and safety











"This will be a useful way to address parents'
concerns and give them something tangible to
take home and read through."
RN
"I think this is so important. The statistics at the
top will catch peoples' attention. That's what
parents need to see."
APRN
"People will be particularly surprised by the
incidence of Head and Neck Cancer. I think
that's a really important one to consider."
RN
"I like the way it is written. It's clear and easy to
read. There is good focus on numbers and





change their mind about
the HPV vaccine can be
evaluated and reported as
HPV vaccination rate in
children whose parents
accepted handout /




HPV vaccination rates at
Brookfield Primary Care
and Pediatrics can be
measured after
implementation of the





Parent interest in receieving
the handout can be
evaluated and reported as
number of parents willing to
accept the handout /
number of handouts offered.
07A
Short time frame
Due to the short time frame
of this project, pre- and
post-handout HPV
vaccination rates were
unable to be measured. 
Lack of parent
feedback
Feedback from parents who
receieve the handout was
unable to be assessed.
There may be superior




The handout addresses a
limited number of obstacles
to HPV vaccination, and









Development of alternative methods 
of information communication
Alternative methods of presenting information about the HPV vaccine
could be developed, including posters or graphics for social media.
Expansion of initiative to other 
family practices, schools, etc.
The handout could be made available to providers in other locations
such as other family practices, schools, and pharmacies.  
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Thank you for agreeing to be interviewed. This project is a
requirement for the Family Medicine clerkship. It will be stored on
the Dana Library ScholarWorks website. Your name will be attached
to your interview and you may be cited directly or indirectly in
subsequent unpublished or published work. The interviewer affirms
that he/she has explained the nature and purpose of this project.
The interviewee affirms that he/she has consented to this interview.
Consented:
Laurie Schedgick-Davis, MD
Darlene Benson, RN
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